NYSE - Nasdaq Real Time Price USD

CVS Health Corporation (CVS)

Compare
56.90
-0.43
(-0.75%)
At close: January 29 at 4:00:02 PM EST
56.00
-0.90
(-1.58%)
Pre-Market: 9:22:41 AM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Roger N. Farah Executive Chairman of the Board 152.5k -- 1953
Mr. Thomas Francis Cowhey Executive VP & CFO 1.83M -- 1972
Mr. Tilak Mandadi Executive VP of Ventures and Chief Digital, Data, Analytics & Technology Officer 2.38M -- 1965
Mr. Samrat S. Khichi Esq. Executive VP, Chief Policy Officer & General Counsel 3.39M -- 1967
Mr. Prem S. Shah Pharm.D Executive VP & Group President 2.58M -- 1980
Mr. J. David Joyner CEBS President, CEO & Director -- -- 1965
Mr. Vijay Patel Senior Director of Business Development & CVS Health and Partner & Co-Founder -- -- --
Mr. James David Clark Senior VP, Controller & Chief Accounting Officer -- -- 1965
Mr. David A. Falkowski Executive VP & Chief Compliance Officer -- -- --
Ms. Heidi B. Capozzi Executive VP & Chief People Officer -- -- 1970

CVS Health Corporation

One CVS Drive
Woonsocket, RI 02895
United States
401 765 1500 https://www.cvshealth.com
Sector: 
Healthcare
Industry: 
Healthcare Plans
Full Time Employees: 
219,000

Description

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Corporate Governance

CVS Health Corporation’s ISS Governance QualityScore as of January 1, 2025 is 2. The pillar scores are Audit: 5; Board: 7; Shareholder Rights: 1; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 3, 2025 at 12:00 AM UTC

Dividend Date

February 12, 2025 at 1:30 PM UTC

CVS Health Corporation Earnings Date

Recent Events

January 23, 2025 at 12:00 AM UTC

Ex-Dividend Date

December 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 10, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 2, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 21, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

November 19, 2024 at 3:20 PM UTC

at Wolfe Research Healthcare Conference

November 18, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 6, 2024 at 1:00 PM UTC

Q3 2024 Earnings Call

Related Tickers